MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Atomik Labz
122 products · 249 listings
Daily snapshot · inspect sources
Capsule comparison
ATX-304 Capsules prices
Compare ATX-304 Capsules listings by strength, selection and supplier. Inspect the original source behind each price.
2suppliers represented
2source-linked listings
1strengths available
GO BEYOND THE PRICE
Track it. Plan it. Inspect it.
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Reports and batch records
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Listed amounts and selections
- 100 mg2 suppliers · Pack counts: 60
Reported quantities in this family: 60. Counts and units must be matched to the exact listing.
Compare the exact selection
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.
Suppliers with ATX-304 Capsules listings
2 profiles
Solution Peptides
153 products · 275 listings
Sources and comparison limits
2 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
Explore more capsule listings
FROM PEPTIDES CALCULATOR
About O-304
Source profile reviewed 2026-10-02 · Imported 2026-10-22. Read the full compound profile
O-304, now developed as ATX-304, is a small-molecule pan-AMPK activator discovered at Umea University and taken into the clinic by the Swedish company Betagenon as an oral drug that mimics some effects of exercise. It raised muscle glucose uptake and lowered fasting glucose in obese mice, and in a 28-day phase 2a trial in 65 people with type 2 diabetes on metformin, 1,000 mg a day lowered fasting glucose, insulin resistance and blood pressure within the treated group even though the main comparison against placebo was not significant. The programme now sits with Cambrian Bio, which reported a phase 1b study at 400 mg a day in adults with obesity and prediabetes in June 2026 and plans phase 2 trials; it is not approved anywhere.
- Formula
- C16 H11 Cl2 N3 O2 S
- Molar mass
- 380.2 g/mol
- CAS number
- 1261289-04-6
Research evidence described in the source
Human studies and registrations
3 protocol rows on this page come from human trials, trial registrations, regulator labels or reviews of human data. Approval status and populations are stated per row.
Preclinical models
2 protocol rows describe animal, cell or toxicology work. Amounts from these rows do not translate to people.
Community-reported use
1 row record what blogs, vendor write-ups or forums describe for O-304. None has been verified against primary literature.
Limitations noted in the source
- Every amount on this page is a report of what a source describes, not a protocol to follow.
- Preclinical and community rows do not establish a human amount, schedule or route.
- Formulation, purity and presentation vary by supplier and are not covered by the dossier.
Publications and references linked by the source
- pubchem.ncbi.nlm.nih.gov/compound/50923806
- www.clinicaltrialsregister.eu/ctr-search/trial/2016-002183-13/results
- insight.jci.org/articles/view/99114
- betagenon.com/research-development/indications/type-2-diabetes
- www.cambrianbio.com/news-and-publications/cambrian-bio-presents-positive-human-translational-data-for-atx-304-the-first-ampk-network-activator-at-the-american-diabetes-associations-86th-scientific-sessions
- pubmed.ncbi.nlm.nih.gov/34795407/
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.